(+/-)-3-(4-AMINO-1H-PYRROLO[2,3-D]PYRIMIDIN-1-YL)-5-(HYDROXYMETHYL)-(ALPHA,2-ALPHA,3-BETA,5-BETA)-1,2-CYCLOPENTANEDIOL, THE CARBOCYCLIC ANALOG OF TUBERCIDIN

被引：13
|
作者：
SECRIST, JA
CLAYTON, SJ
MONTGOMERY, JA
机构：
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1984年 / 27卷 / 04期
关键词：
D O I：
10.1021/jm00370a018
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：534 / 536
页数：3
相关论文
共 50 条
  • [41] CARCINOGENICITY STUDY OF 3-(5-NITRO-2-FURYL)-IMIDAZO (1,2-ALPHA) PYRIDINE IN MICE AND RATS
    CABRAL, JR
    ROSSI, L
    DRAGANI, TA
    DELLAPORTA, G
    TUMORI JOURNAL, 1980, 66 (02): : 131 - 144
  • [42] C-13-H-1 COUPLING-CONSTANTS IN CARBOCATIONS .8. APPLICATION OF THE DELTA-J EQUATION TO TERTIARY DICYCLOPROPYLCARBINYL CATIONS - THE METHYL DICYCLOPROPYLCARBINYL, (1-ALPHA,3-BETA,5-BETA,7-ALPHA)-2-METHYLTRICYCLO [5.1.0.0(3,5)]OCTAN-2-YL, (1-ALPHA,3-ALPHA,5-ALPHA,7-ALPHA)-2-METHYLTRICYCLO[5.1.0.0(3,5)]OCTAN-2-YL, AND 3-METHYLTETRACYCLO[3.3.1.0(2,8).0(4,6)]NONAN-3-YL (TRIASTERYL) CATIONS
    KELLY, DP
    BANWELL, MG
    RYAN, JH
    PHYLAND, JR
    QUICK, JR
    JOURNAL OF ORGANIC CHEMISTRY, 1995, 60 (06): : 1651 - 1657
  • [43] 1 beta-Amino-2 alpha,3 beta,5 beta-trihydroxycycloheptane from Physalis alkekengi var Francheti
    Asano, N
    Kato, A
    Kizu, H
    Matsui, K
    PHYTOCHEMISTRY, 1996, 42 (03) : 719 - 721
  • [44] 1-{3-(4-Methylphenyl)-5-[5-(2-nitrophenyl)furan-2-yl]-4,5-dihydro-1H-pyrazol-1-yl}ethanone
    Vinutha, N.
    Kumar, S. Madan
    Jois, B. S. Vidyashree
    Balakrishna, Kalluraya
    Lokanath, N. K.
    Revannasiddaiah, D.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1528 - +
  • [45] BOND LENGTH AND REACTIVITY - STRUCTURE OF A GROB FRAGMENTATION SUBSTRATE, 4A-ALPHA,5-BETA,8A-BETA-1-METHYLDECAHYDROQUINOLIN-5-YL 3,5-DINITROBENZOATE
    JONES, PG
    EDWARDS, MR
    KIRBY, AJ
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1986, 42 : 1372 - 1374
  • [46] SYNTHESIS OF 3-(1,2,4-TRIAZOL-1-YL)-2,3-DIDEOXY-D-ARABINO-HEXOPYRANOSYL AND 3-(1,2,4-TRIAZOL-1-YL)-2,3-DIDEOXY-D-RIBO-HEXOFURANOSYL URACILS VIA AN ALPHA,BETA-UNSATURATED ALDEHYDOHEXOSE
    WALCZAK, K
    PEDERSEN, EB
    SYNTHESIS-STUTTGART, 1991, (11): : 959 - 962
  • [47] Ethyl 7-Methyl-5-(4-methylphenyl)-3-oxo-2-{[3-(3,4-dichlorophenyl)-1-phenyl-1H-pyrazol-4-yl]methylidene}-2,3-dihydro-5H-[1,3]thiazolo[3,2-alpha]pyrimidine-6-carboxylate
    Viveka, Shivapura
    Dinesha
    Laxmeshwar, Sandeep Sadananda
    Nagaraja, Gundibasappa Karikannar
    MOLBANK, 2012, (03) : 1 - 5
  • [48] Synthesis of novel pyrrylthieno[2,3-d]pyrimidines and related pyrrolo[1",2":1′,6′]pyrazino[2′,3′:4,5] thieno[2,3-d]pyrimidinies
    Bakhite, EA
    Geies, AA
    El-Kashef, HS
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2002, 177 (02) : 303 - 323
  • [49] Synthesis of [3H]-labelled 4-[Ethyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2,3-[3H]-butan-1-ol:: a high affinity radioligand for the corticotropin-releasing hormone type 1 receptor
    Hiebel, Anne-Cecile
    Partilla, John S.
    Rothman, Richard B.
    Jacobson, Arthur E.
    Rice, Kenner C.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2006, 49 (07): : 635 - 640
  • [50] 2-ALPHA,3-ALPHA-EPITHIO-5-ALPHA-ANDROSTAN-17-BETA-YL 1-METHOXYCYCLOPENTYL ETHER IN TREATMENT OF ADVANCED BREAST CANCER - PRELIMINARY CLINICAL TRIAL
    KUMAOKA, S
    TAKATANI, O
    YOSHIDA, M
    MIURA, S
    TAKAO, T
    HAMANAKA, Y
    IZUO, M
    OKADA, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1974, 4 (01) : 65 - 68
12345